Industry challenges we solve
Life sciences teams rarely struggle to describe what the software should do. They struggle to get it built, validated and kept in a validated state without every change turning into a months long project.
Validated software that survives an inspection. We build lab, clinical, safety and supply chain systems for pharma, biotech and CROs with audit trails, electronic signatures and validation evidence designed in from the first sprint, not reconstructed before go live. Senior engineers own the architecture, AI coding agents carry the volume, and every line is reviewed by a human.
Key highlights
Life sciences teams rarely struggle to describe what the software should do. They struggle to get it built, validated and kept in a validated state without every change turning into a months long project.
We build and extend GxP systems with the controls inspectors look for, and deliver the validation package alongside the code.
Instrument interfaces, sample management workflows, stability study scheduling and ELN integration. Raw data is captured directly from instruments and chromatography data systems, so there is no transcription step to audit.
ePRO and eCOA apps, site and patient portals, randomisation and supply integrations, and data pipelines to CDISC SDTM and ADaM. Designed around ICH E6(R3) good clinical practice expectations.
Adverse event intake from forms, email and call centres, duplicate detection, MedDRA coding support and ICH E2B(R3) case exchange with Argus, ARISg or your safety database.
GS1 EPCIS 2.0 event processing, aggregation and exception handling for DSCSA in the US and EU FMD verification through the national systems, connected to packaging line and ERP data.
Deviations, CAPA, change control, training records and document control, with electronic signatures that meet Part 11 requirements for signature manifestation and record linking.
User requirements, risk assessments, IQ, OQ and PQ evidence and traceability matrices produced from the same pipeline that builds the software, so re-validation after a change takes days rather than months.
We document what the system does, which GxP records it creates and where patient safety or data integrity risk sits. Output: a validation plan sized to that risk, not a template.
Requirements are traced to code and automated tests from the first sprint. Each build produces test evidence your QA team can review and approve.
Installation and operational qualification in your validated environment, user acceptance with your SMEs, and a validation summary report ready for QA sign off.
Change control, periodic review support and fast, risk based re-validation so the system can keep improving after go live.
In life sciences the question is not only whether the software works, but whether you can prove it works and that its records can be trusted. We plan for that from the first conversation.
Electronic records and signatures by design. Secure, time stamped audit trails capture who did what, when, the old and new values and the reason for change. Electronic signatures are linked to their records and show the signer, date and meaning, as Part 11 and Annex 11 expect.
Validation effort follows risk. We apply GAMP 5 categories and critical thinking in the spirit of FDA Computer Software Assurance: rigorous scripted testing for high risk functions, and lighter unscripted or automated assurance where risk is low. The rationale is documented for your QA team and inspectors.
Patient data stays protected. Clinical and safety systems that handle personal health information get HIPAA safeguards for US data and GDPR controls for EU and UK subjects, including pseudonymisation, access logging and data residency in your chosen region.
Proven, supportable technology that your IT and QA teams can maintain, with integration adapters for the validated platforms you already run.
Tell us about the process and the records it creates. Written scope, timeline and cost estimate within 48 hours.